Zetomipzomib | Interleukin Related interleukin-related.com

Product Name :
Zetomipzomib

Search keywords :
Zetomipzomib

drugId :
null

Target Vo:
Proteasome

Target Vo Short Name :
Proteasome

Moa_Name:
Proteasome inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Onyx Pharmaceuticals Inc

Active Company_Name :
Everest Medicines (China) Co Ltd

Active Indication_Name:
Lupus Nephritis

In Active Indication_Name:
Purpura, Thrombocytopenic, Idiopathic

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Myc-tag Antibody
ATP citrate lyase Antibody
Adipose Triglyceride Lipase Antibody: Adipose Triglyceride Lipase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Adipose Triglyceride Lipase. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts